BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 12404725)

  • 21. Histological subtyping and nuclear grading of renal cell carcinoma and their implications for survival: a retrospective nation-wide study of 629 patients.
    Gudbjartsson T; Hardarson S; Petursdottir V; Thoroddsen A; Magnusson J; Einarsson GV
    Eur Urol; 2005 Oct; 48(4):593-600. PubMed ID: 15964127
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Survival analysis of clear cell renal carcinoma according to the Charlson comorbidity index.
    Santos Arrontes D; Fernández Aceñero MJ; García González JI; Martín Muñoz M; Paniagua Andrés P
    J Urol; 2008 Mar; 179(3):857-61. PubMed ID: 18221956
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Nephron-sparing surgery for small renal cell carcinoma: clinical analysis of 21 cases].
    Xiao YJ; Zheng SB; Tan WL; Chen T; Qi H; Shao ZQ; Jiang YD; Wu P; Zhang HJ
    Di Yi Jun Yi Da Xue Xue Bao; 2005 Mar; 25(3):357-9. PubMed ID: 15772014
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Percentage of high-grade carcinoma as a prognostic indicator in patients with renal cell carcinoma.
    Serrano MF; Katz M; Yan Y; Kibel AS; Humphrey PA
    Cancer; 2008 Aug; 113(3):477-83. PubMed ID: 18484589
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-term survival of patients with unilateral sporadic multifocal renal cell carcinoma according to histologic subtype compared with patients with solitary tumors after radical nephrectomy.
    Dimarco DS; Lohse CM; Zincke H; Cheville JC; Blute ML
    Urology; 2004 Sep; 64(3):462-7. PubMed ID: 15351571
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Morphological subtyping of papillary renal cell carcinoma: clinicopathological characteristics and prognosis.
    Yamashita S; Ioritani N; Oikawa K; Aizawa M; Endoh M; Arai Y
    Int J Urol; 2007 Aug; 14(8):679-83. PubMed ID: 17681054
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cystic renal cell carcinoma: biology and clinical behavior.
    Han KR; Janzen NK; McWhorter VC; Kim HL; Pantuck AJ; Zisman A; Figlin RA; Dorey FJ; Said JW; Belldegrun AS
    Urol Oncol; 2004; 22(5):410-4. PubMed ID: 15464922
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Young age is independent prognostic factor for cancer-specific survival of low-stage clear cell renal cell carcinoma.
    Jung EJ; Lee HJ; Kwak C; Ku JH; Moon KC
    Urology; 2009 Jan; 73(1):137-41. PubMed ID: 18950844
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Pulmonary resections for metastatic renal cell carcinoma in Iceland].
    Oddsson SJ; Isaksson HJ; Jonsson E; Einarsson GV; Gudbjartsson T
    Laeknabladid; 2008 May; 94(5):377-81. PubMed ID: 18460734
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Renal cell cancer stage migration: analysis of the National Cancer Data Base.
    Kane CJ; Mallin K; Ritchey J; Cooperberg MR; Carroll PR
    Cancer; 2008 Jul; 113(1):78-83. PubMed ID: 18491376
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cytoreductive nephrectomy for metastatic renal cell carcinoma with nonclear cell histology.
    Kassouf W; Sanchez-Ortiz R; Tamboli P; Tannir N; Jonasch E; Merchant MM; Matin S; Swanson DA; Wood CG
    J Urol; 2007 Nov; 178(5):1896-900. PubMed ID: 17868729
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differential expression of caveolin-1 in renal neoplasms.
    Tamaskar I; Choueiri TK; Sercia L; Rini B; Bukowski R; Zhou M
    Cancer; 2007 Aug; 110(4):776-82. PubMed ID: 17594718
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Adult renal neoplasms in the material of the Pathology Department of the Szeged University].
    Németh I; Sükösd F; Béli L; Kiss A; Pajor L; Mikó T; Iványi B
    Orv Hetil; 2005 Apr; 146(14):653-8. PubMed ID: 15889540
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Characterization and staging of renal tumors: significance of MRI diagnostics].
    Kalinka A; Gerlach A; Arlart IP; Günes N; Hauser TK; Würstlin S; Bosse A
    Rofo; 2006 Mar; 178(3):298-305. PubMed ID: 16508837
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pathobiology and prognosis of chromophobe renal cell carcinoma.
    Klatte T; Han KR; Said JW; Böhm M; Allhoff EP; Kabbinavar FF; Belldegrun AS; Pantuck AJ
    Urol Oncol; 2008; 26(6):604-9. PubMed ID: 18367104
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognosticfactors in patients with renal cell carcinoma: is TNM (1997) staging relevant in Indian subpopulation?
    Srivastava A; Mandhani A; Kapoor R; Jain M; Dubey D; Srivastava A; Raghavendra M; Kumar A
    Indian J Cancer; 2004; 41(3):99-103. PubMed ID: 15472406
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Anaplastic sarcoma of the kidney: a clinicopathologic study of 20 cases of a new entity with polyphenotypic features.
    Vujanić GM; Kelsey A; Perlman EJ; Sandstedt B; Beckwith JB
    Am J Surg Pathol; 2007 Oct; 31(10):1459-68. PubMed ID: 17895746
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Spoke-wheel-like enhancement as an important imaging finding of chromophobe cell renal carcinoma: a retrospective analysis on computed tomography and magnetic resonance imaging studies.
    Kondo T; Nakazawa H; Sakai F; Kuwata T; Onitsuka S; Hashimoto Y; Toma H
    Int J Urol; 2004 Oct; 11(10):817-24. PubMed ID: 15479284
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effect of bilaterality, pathological features and surgical outcome in nonhereditary renal cell carcinoma.
    Blute ML; Itano NB; Cheville JC; Weaver AL; Lohse CM; Zincke H
    J Urol; 2003 Apr; 169(4):1276-81. PubMed ID: 12629342
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Detection, staging and clinical implications of renal cell carcinoma.
    Ghalayini IF; Bani-Hani IH
    Saudi Med J; 2003 Jan; 24(1):79-83. PubMed ID: 12590282
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.